Tandem Diabetes Care Inc (TNDM)

0.67
NASDAQ : Health Care
Prev Close 0.62
Day Low/High 0.62 / 0.69
52 Wk Low/High 0.39 / 8.81
Avg Volume 552.40K
Exchange NASDAQ
Shares Outstanding 50.23M
Market Cap 31.14M
EPS -2.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Tandem Diabetes Care To Present At The 2017 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care To Present At The 2017 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care Reports Second Quarter 2017 Financial Results

Tandem Diabetes Care Reports Second Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its second quarter 2017 results after the...

Tandem Diabetes Care Presents Findings From Predictive Low Glucose Suspend (PLGS) Feasibility Study And Announces Approval Of Investigational Device Exemption (IDE) For Pivotal Trial

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today presented results from a feasibility study for its...

Short Interest Makes 14.4% Move For TNDM

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 357,165 share increase in total short interest for Tandem Diabetes Care Inc , to 2,838,888, an increase of 14.39% since 04/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Tandem Diabetes Care Reports First Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care To Present At The Deutsche Bank 42nd Annual Health Care Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care Schedules First Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its first quarter 2017 results after the...

Tandem Diabetes Care Launches New T:connect Diabetes Management Application Portal For Healthcare Providers

Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the launch of the t:connect ® HCP Portal.

Tandem Diabetes Care Announces Pricing Of Underwritten Public Offering Of Common Stock

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the pricing of an underwritten public offering...

Tandem Diabetes Care Announces Filing Of Registration Statement For Proposed Follow-on Public Offering Of Common Stock

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has filed a registration statement on...

Tandem Diabetes Care Reports 2016 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the year and quarter...

Tandem Diabetes Care Announces Plans For Improved Infusion Set Connector Developed From Customer Feedback

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced plans to implement a new infusion set...

Tandem Diabetes Care Launches First Ever Remote Software Update For Insulin Pump Using A Personal Computer

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the release of a software update for...

Tandem Diabetes Care Schedules Fourth Quarter And Full Year 2016 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its fourth quarter and full year 2016 results...

Data Presented At ATTD 2017 Demonstrate Clinical Advantages Of Tandem Diabetes Care Sensor-augmented Pump (SAP) Over Medtronic MiniMed SAPs

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today presented study results comparing retrospective user...

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.

Tandem Diabetes Care To Draw Down $35 Million Under Existing Term Loan Facility With CRG

Tandem Diabetes Care To Draw Down $35 Million Under Existing Term Loan Facility With CRG

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced that it has initiated the drawdown of $35 million under the company's previously announced term loan facility with Capital Royalty Partners II L.

Tandem Diabetes Care To Present At The 28th Annual Piper Jaffray Healthcare Conference

Tandem Diabetes Care To Present At The 28th Annual Piper Jaffray Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

(Graphic: Business Wire)

(Graphic: Business Wire)

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.

Tandem Diabetes Care Enters Oversold Territory (TNDM)

Tandem Diabetes Care Enters Oversold Territory (TNDM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tandem Diabetes Care Reports Third Quarter 2016 Financial Results

Tandem Diabetes Care Reports Third Quarter 2016 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care Announces Earlier Date For Q3 2016 Earnings Results And Conference Call

Tandem Diabetes Care Announces Earlier Date For Q3 2016 Earnings Results And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, now plans to release its third quarter 2016 results after the...

Commit To Buy Tandem Diabetes Care At $5, Earn 10.1% Annualized Using Options

Commit To Buy Tandem Diabetes Care At $5, Earn 10.1% Annualized Using Options

Investors eyeing a purchase of Tandem Diabetes Care Inc stock, but tentative about paying the going market price of $6.75/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $5 strike, which has a bid at the time of this writing of 20 cents.

Tandem Diabetes Care Now Shipping Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care Now Shipping Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced commencement of shipments for its...

Tandem Diabetes Care Schedules Third Quarter 2016 Earnings Press Release And Conference Call

Tandem Diabetes Care Schedules Third Quarter 2016 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its third quarter 2016 results after the...

Tandem Diabetes Care Now Taking Orders For Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care Now Taking Orders For Next-Generation T:slim X2 Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it is now accepting orders for its...